Can 'personalized diagnostics' promote earlier intervention for dysglycaemia? Hypothesis ready for testing

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 1, 2010, Pages 7-9

  Dankner, Rachel ^a,b   Danoff, Ann ^c   Roth, Jesse ^d,e  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; DIABETES MELLITUS; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIVIDUALIZED MEDICINE; INSULIN; REFERENCE VALUES;

EID: 75449106771     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1039     Document Type: Review

References (10)

1. Garber AJ, HandelsmanY, EinhornD, et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008; 14(7): 933-946.
2. Bergman M. Inadequacies of absolute threshold levels for diagnosing prediabetes. DMRR 2010; 26: 3-6.
3. Mason CC, Hanson RL, Knowler WC. Progression to type 2 diabetes is characterized by moderate then rapid glucose increases. Diabetes 2007; 56: 2054-2061.
4. The International Expert Committee. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
5. Bloomgarden ZT, Inzucchi SE, Karnieli E, Le Roith D. The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted. Diabetologia 2008; 51: 1111-1114. Epub 2008 May 1. Review.
6. Bloomgarden ZT. Diabetes treatment and measures of glycemia. Diabetes Care 2009; 32: e39-e43.
7. ShanikMH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008; 31(Suppl. 2): S262-S268. Review.
8. Ceriello A, Esposito K, Ihnat M, Thorpe J, Giugliano D. Longterm glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. J Clin Endocrinol Metab 2009; 94: 2751-2756.
9. Tirosh A, Shai I, Bitzur R, et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care 2008; 31(10): 2032-2037. Epub 2008 Jun 30.
10. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl JMed 2002; 346(6): 393-403.